Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice
Author:
Funder
Ontario Ministry of Health and Long-Term Care (MOHLTC)
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference31 articles.
1. Perioperative chemotherapy for colorectal cancer liver metastases;Clancy;Oncology (Williston Park),2013
2. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making;Schmoll;Ann Oncol,2012
3. Surgical resection and peri-operative chemotherapy for colorectal cancer liver metastases: a population-based study;Booth;Eur J Surg Oncol,2016
4. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials;Mitry;J Clin Oncol,2008
5. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial;Nordlinger;Lancet,2008
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 2-4 weeks is the optimal time to operate on colorectal liver metastasis after neoadjuvant chemotherapy;BioScience Trends;2023-04-30
2. An empirical review on the resistance mechanisms of epidermal growth factor receptor inhibitors and predictive molecular biomarkers in colorectal cancer;Critical Reviews in Oncology/Hematology;2023-03
3. Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot?;Journal of Clinical Oncology;2021-12-01
4. Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer: A Systematic Review and Meta-Analysis;World Journal of Surgery;2021-07-28
5. Association of lncRNA‑p53 regulatory network (lincRNA‑p21, lincRNA‑ROR and MALAT1) and p53 with the clinicopathological features of colorectal primary lesions and tumors;Oncology Letters;2020-04-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3